Repligen Corporation (NASDAQ:RGEN) Shares Could Be 23% Below Their Intrinsic Value Estimate
Key Insights Repligen's estimated fair value is US$188 based on 2 Stage Free Cash Flow to Equity Repligen's US$145 share price signals that it might be 23% undervalued Our fair value estimate is 2.3%...